Drug
Gsk1014802 Low Dose
Gsk1014802 Low Dose: highest development phase Phase 1, developed by Biogen. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Biogen
Trials
| Drug | Phase | Indication |
|---|---|---|
| GSK1014802 low dose NCT00964288 | Phase 1 | Pain, Neuropathic |
Latest
No recent events.
Follow Gsk1014802 Low Dose on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.